ESR1 and breast cancer: An RNAseq analysis of invasive breast cancer specimens from the TCGA highlighted a negative correlation between IDO1 and ESR1 gene expression, along with a significant downregulation of IDO, specifically in luminal A and B BC subtypes [71].